ethyl rosmarinate

CAS No. 174591-47-0

ethyl rosmarinate( Methyl rosmarinate )

Catalog No. M23787 CAS No. 174591-47-0

Methyl rosmarinate inhibit the activity of tyrosinase, α-glucosidase, and matrix metalloproteinase-1 (MMP-1).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 163 In Stock
5MG 155 In Stock
10MG 242 In Stock
25MG 410 In Stock
50MG 594 In Stock
100MG 846 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    ethyl rosmarinate
  • Note
    Research use only, not for human use.
  • Brief Description
    Methyl rosmarinate inhibit the activity of tyrosinase, α-glucosidase, and matrix metalloproteinase-1 (MMP-1).
  • Description
    Methyl rosmarinate inhibit the activity of tyrosinase, α-glucosidase, and matrix metalloproteinase-1 (MMP-1).
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Methyl rosmarinate
  • Pathway
    Proteasome/Ubiquitin
  • Target
    Tyrosinase
  • Recptor
    Tyrosinase|α-glucosidase|MMP-1
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    174591-47-0
  • Formula Weight
    388.37
  • Molecular Formula
    C20H20O8
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CCOC([C@@H](Cc(cc1)cc(O)c1O)OC(/C=C/c(cc1)cc(O)c1O)=O)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Lin L , Dong Y , Zhao H , et al. Comparative evaluation of rosmarinic acid, methyl rosmarinate and pedalitin isolated from Rabdosia serra (MAXIM.) HARA as inhibitors of tyrosinase and α-glucosidase[J]. Food Chemistry, 2011, 129(3):884-889.
molnova catalog
related products
  • Glycolic acid

    Glycolic acid is an inhibitor of tyrosinase suppressing melanin formationand used in skincare products

  • Citraconic acid

    Citraconic acid is a dicarboxylic acid consisting of maleic acid having a methyl substituent at the 2-position.

  • NDI-034858

    NDI-034858 (TAK-279) is a tyrosine kinase 2 (TYK2) inhibitor (Kd<200 pM) that targets the JH2 structural domain of Tyk2 for the treatment of autoimmune diseases caused by aberrant expression of IL12 and IL23.